4年之前中
東
地區藥品市場預
測：政策環境�
B�
場結構、�
v爭動向、成長機會" href="http://faq.squeezingprettyexposedmomanddaughter.com/feed//ro/Files/Personal%20Power/Seduction/David%20DeAngelo%20-%20Attraction%20isnt%20a%20Choice.pdf" />
[市場調查報告書] 201<img src="http://www.aigando.com/images17/amo's-Pretty-3.jpg"/>4年之前中<img src="http://www.vod-pornos.com/covers/10/105126_thumbnail.jpg"/>東<img src="http://i162.photobucket.com/albums/t271/4wheelinbro/DSC01622.jpg"/>地區藥品市場預<img src="http://www.truthordarepics.com/enf/images/exposed-thong.jpg"/>測：政策環境�<img src="http://www.sdpix.com/images/events/exposed_2009.jpg"/>B�<img src="http://finbar.dyndns.org/~tgs/pix/06Habitat/Tom,%20won't%20your%20mom%20be%20pleased%20to%20see%20you%20up%20here%20.%20.%20..jpg"/>場結構、�<img src="http://bayes.wustl.edu/etj/mom.jpg"/>v爭動向、成長機會
Daughter Squeezing Pretty
[市場調查報告書] 201
4年之前中東地區藥品市場預測：政策環境�B�場結構、�v爭動向、成長機會
Faq Squeezingprettyexposedmomanddaughter Ro Files Personal%20Power Seduction David%20DeAngelo%20 %20Attraction%20isnt%20a%20Choice Pdf Squeezing Pretty Exposed Mom And Daughter
Table of Contents
Executive Summary
- The macroeconomic environment in the Middle East
- Healthcare systems in the Middle East
- Pharmaceutical market analysis of the Middle East
- Competitive landscape of the Middle Eastern pharmaceutical market
- Scope and Methodology
- Scope
- Methodology
Chapter 1 The macroeconomic environment in the Middle East
- Summary
- Introduction
- Population profile
- Disease burden
- Macroeconomic comparison of the Middle East
- Economic landscape of key Middle Eastern countries
- Egypt
- Turkey
- Saudi Arabia
- Israel
- Jordan
- UAE
- Lebanon
- Kuwait
Chapter 2 Healthcare systems in the Middle East
- Summary
- Introduction
- Profiles of the healthcare systems across Middle Eastern countries
- Egypt
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Turkey
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Saudi Arabia
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Israel
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Jordan
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- UAE
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Lebanon
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Kuwait
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
Chapter 3 Pharmaceutical Market analysis in the Middle East
- Summary
- Introduction
- Pharmaceutical market overview
- Therapy area analysis
- Therapy area sales forecast
- Therapy area analysis by country
- Egypt
- Turkey
- Saudi Arabia
- Israel
- Jordan
- UAE
- Lebanon
- Kuwait
- Leading brands analysis
- Seretide (GSK)
- Lipitor (Pfizer)
- Augmentin (GSK/MUP)
- Glivec (Novartis)
- Co-Diovan (Novartis)
- Spiriva (Boehringer Ingelheim)
- Plavix (Sanofi-Aventis)
- Cipralex (Lundbeck)
- Lansor (Sanovel)
- Symbicort (AstraZeneca)
- Leading brands sales forecast
- Key brand analysis by country
- Egypt
- Flumox and Cefotax (Eipico)
- Amaryl (Sanofi-Aventis)
- Cataflam (Novartis)
- Augmentin (MUP)
- Turkey
- Foradil Combi (Novartis)
- Taxotere (Sanofi-Aventis)
- Herceptin (Roche)
- Saudi Arabia
- Augmentin (GSK)
- Snafi (Spimaco)
- Viagra (Pfizer)
- Nexium (AstraZeneca)
- Israel
- Norditropin (Novo Nordisk)
- Seretide (GSK)
- Tritace (Sanofi-Aventis)
- Jordan
- Amoclan (Hikma)
- Similac Gain and Similac Advance (Abbott Nutrition)
- Cerelac (Nestle)
- United Arab Emirates
- Cialis (Eli Lilly)
- Plavix (Sanofi-Aventis)
- Zinnat (GSK)
- Lebanon
- Pariet (J&J)
- Concor (Merck KGaA)
- Crestor (AstraZeneca)
- Kuwait
- Rocephin (Roche)
- Xenical (Roche)
- Yasmin (Bayer)
Chapter 4 Competitive landscape of the Middle Eastern pharmaceutical market
- Summary
- Introduction
- Leading players
- Analysis of key players in the Middle East
- Novartis
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Novartis' pipeline focus
- Strategic growth analysis
- GSK
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- GSK' s pipeline focus
- Strategic growth analysis
- Sanofi-Aventis
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Sanofi-Aventis pipeline focus
- Strategic growth analysis
- Pfizer
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Pfizer' s pipeline focus
- Strategic growth analysis
- Ibrahim
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Ibrahim' s pipeline focus
- Strategic growth analysis
- Leading players analysis by country
- Egypt
- Turkey
- Saudi Arabia
- Israel
- Jordan
- UAE
- Lebanon
- Kuwait
Chapter 5 Appendix